These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6388448)

  • 21. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability.
    Silverstein MJ; Gierson ED; Waisman JR; Colburn WJ; Gamagami P
    J Am Coll Surg; 1995 Jun; 180(6):700-4. PubMed ID: 7773483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occult breast cancer presenting with axillary metastasis.
    Svastics E; Rónay P; Bodó M
    Eur J Surg Oncol; 1993 Dec; 19(6):575-80. PubMed ID: 8270047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of occult metastases in axillary sentinel lymph nodes of breast carcinoma.
    Amir AS; Azar FP; Sahram N; Naser FM; Na'ma MR; Farid F; Khatoon AN; Ramin S; Ali TK
    Pol J Pathol; 2012 Mar; 63(1):40-4. PubMed ID: 22535605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary lymph node status and prognosis in multifocal and multicentric breast carcinoma.
    Duraker N; Caynak ZC
    Breast J; 2014; 20(1):61-8. PubMed ID: 24438065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral axillary metastases of occult breast carcinoma: report of a case with a review of the literature.
    Steunebrink M; Schnater JM; Storm RK; van Ingen G; Vegt PA; Plaisier PW
    Breast; 2005 Apr; 14(2):165-8. PubMed ID: 15767189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
    Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance and staging of nonpalpable carcinomas of the breast.
    Schwartz GF; Feig SA; Patchefsky AS
    Surg Gynecol Obstet; 1988 Jan; 166(1):6-10. PubMed ID: 2827328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma of the breast with axillary lymph node metastasis.
    Mendelsohn LA; Atkinson WE; Knox MF; Langston HD
    J Ark Med Soc; 1987 Sep; 84(4):175-6. PubMed ID: 2959651
    [No Abstract]   [Full Text] [Related]  

  • 32. 'Occult' breast cancer.
    Lloyd MS; Nash AG
    Ann R Coll Surg Engl; 2001 Nov; 83(6):420-4. PubMed ID: 11777139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph node axillary metastasis from occult contralateral infiltrating lobular carcinoma arising in accessory breast: MRI diagnosis.
    Capobianco G; Spaliviero B; Dessole S; Rocca PC; Cherchi PL; Ambrosini G; Meloni F; Meloni GB
    Breast J; 2007; 13(3):305-7. PubMed ID: 17461909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case regarded as an occult breast cancer treated without mastectomy].
    Kawashima T; Miyazawa Y; Sakata H; Matsubara H; Ryu M; Ochiai T
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):825-8. PubMed ID: 15984524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases.
    Wilkinson EJ; Hause LL; Hoffman RG; Kuzma JF; Rothwell DJ; Donegan WL; Clowry LJ; Almagro UA; Choi H; Rimm AA
    Pathol Annu; 1982; 17 Pt 2():67-91. PubMed ID: 7182759
    [No Abstract]   [Full Text] [Related]  

  • 37. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
    Karam AK; Stempel M; Barakat RR; Morrow M; Gemignani ML
    Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Axillary Lymph Nodes Metastases from Occult Breast Cancer Recurrence at Ten Years after Resection--Case Report].
    Nagashima S; Sakurai K; Suzuki S; Sakagami M; Adachi K; Enomoto K; Amano S
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1776-8. PubMed ID: 26805169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Occult carcinoma of the breast presenting as an axillary node enlargement].
    Murai H; Yoshida M; Miura S
    Nihon Geka Gakkai Zasshi; 1989 Dec; 90(12):2015-20. PubMed ID: 2696879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognosis of operable breast cancers in women aged under forty years].
    Bobin JY; Mignotte H; Catimel G; Rivoire M; Plat R; Canelo R; Jaime G
    Bull Cancer; 1991; 78(9):819-29. PubMed ID: 1751833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.